BT-7480 by Bicycle Therapeutics for Gastric Cancer: Likelihood of Approval

BT-7480 is under clinical development by Bicycle Therapeutics and currently in Phase II for Gastric Cancer.

Oncology Software: The Digital Backbone of Cancer Care

Annmarie Ison, Head of Customer Service for the Oncology Software Solutions Business Line at Elekta The complex and dynamic landscape of multimodal cancer care is

August 28, 2023

Researchers uncover crucial role of collateral blood vessels in stroke recovery

Blood vessels that cross-connect adjacent arterial trees regulate blood flow to the brain in stroke patients.

February 26, 2024

Ozempic linked to lower opioid overdose rate in those with diabetes, study shows

People taking semaglutide medications like Ozempic for diabetes may be at reduced risk of drug overdose, according to new research. Prescriptions for semaglutide, which includes

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.